perylene has been researched along with Adenocarcinoma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedoročko, P; Sačková, V; Šemeláková, M | 1 |
| Bai, H; Liu, Q; Liu, Y; Wang, H; Wang, P; Wang, X; Zhang, K | 1 |
| Kılıç Süloğlu, A; Selmanoğlu, G; Sünnetçioğlu, MM; Yonar, D | 1 |
| Fedoročko, P; Gyurászová, K; Halaburková, A; Jendželovský, R; Mikeš, J | 1 |
| Fedoročko, P; Jendželovský, R; Šemeláková, M | 1 |
| Fecková, B; Ilkovičová, L; Kello, M; Kimáková, P; Sačková, V; Solár, P; Solárová, Z | 1 |
| Fedorocko, P; Hofmanová, J; Jendzelovský, R; Kello, M; Koval', J; Kozubík, A; Mikes, J; Procházková, J; Sacková, V; Soucek, K | 1 |
| Fedoročko, P; Hofmanová, J; Hýžďalová, M; Jendželovský, R; Kočí, L; Kovaľ, J; Kozubík, A; Mikeš, J; Vaculová, A | 1 |
| Fedoročko, P; Kello, M; Kuliková, L; Sačková, V; Uhrinová, I | 1 |
| Fedoročko, P; Jendželovský, R; Mikeš, J; Šemeláková, M | 1 |
| Höpfner, M; Kashtan, H; Lenz, M; Maaser, K; Riecken, EO; Scherübl, H; Sutter, AP; Theiss, A; von Lampe, B; Zeitz, M | 1 |
| Koyabu, N; Morimoto, S; Ohtani, H; Sawada, Y; Shoyama, Y; Tian, R | 1 |
| Chowbay, B; Lye, KY; Moore, S; Olivo, M; Sharma, A; Zhou, Q | 1 |
| Fedorocko, P; Hofmanová, J; Horváth, V; Jamborová, E; Kleban, J; Kozubík, A; Mikes, J; Sacková, V; Vaculová, A | 1 |
| Pang, SZ; Weng, M; Yang, HY; Zhang, MH; Zhang, WG; Zhang, ZY; Zhao, HX | 1 |
| Cao, GD; Ma, LP; Wang, SW; Zhang, WG; Zhang, ZY | 1 |
| Colasanti, A; Kisslinger, A; Liuzzi, R; Quarto, M; Riccio, P; Roberti, G; Tramontano, D; Villani, F | 1 |
| Blank, M; Keisari, Y; Lavie, G; Mandel, M | 1 |
| Hjortland, GO; Iani, V; Ma, LW; Moan, J; Steen, HB; Uzdensky, AB | 1 |
| Greenblatt, DJ; Perloff, MD; Shader, RI; Störmer, E; von Moltke, LL | 1 |
1 trial(s) available for perylene and Adenocarcinoma
| Article | Year |
|---|---|
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Anthracenes; Antineoplastic Agents; Chemotherapy, Adjuvant; Drug Screening Assays, Antitumor; Gene Expression; Indoles; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Oxindoles; Perylene; Photochemotherapy; Propionates; Protein-Tyrosine Kinases; Proteins; Pyrroles; Survival Rate | 2005 |
19 other study(ies) available for perylene and Adenocarcinoma
| Article | Year |
|---|---|
The potential of hypericin and hyperforin for antiadhesion therapy to prevent metastasis of parental and oxaliplatin-resistant human adenocarcinoma cells (HT-29).
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Cell Adhesion; Cell Movement; Colonic Neoplasms; Drug Resistance, Neoplasm; HT29 Cells; Humans; Neoplasm Metastasis; Oxaliplatin; Perylene; Phloroglucinol; Terpenes | 2018 |
Comparison of hypocrellin B-mediated sonodynamic responsiveness between sensitive and multidrug-resistant human gastric cancer cell lines.
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Perylene; Quinones; Reactive Oxygen Species; Stomach Neoplasms; Tumor Cells, Cultured; Ultrasonic Therapy | 2019 |
An Electron paramagnetic resonance (EPR) spin labeling study in HT-29 Colon adenocarcinoma cells after Hypericin-mediated photodynamic therapy.
Topics: Adenocarcinoma; Anthracenes; Cell Membrane; Colonic Neoplasms; Computer Simulation; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; HT29 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Hypericum; Membrane Fluidity; Neoplasm Recurrence, Local; Perylene; Photochemotherapy; Photosensitizing Agents; Plant Extracts; Spin Labels | 2019 |
YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anthracenes; Antineoplastic Agents; Autophagy; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Membrane Potential, Mitochondrial; Naphthoquinones; Perylene; Photochemotherapy; Photosensitizing Agents; Survivin | 2016 |
Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.
Topics: Adenocarcinoma; Anthracenes; Blotting, Western; Cell Line, Tumor; Colonic Neoplasms; Cytochrome P-450 CYP3A; Firefly Luciferin; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Intracellular Space; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Neoplasm Proteins; Perylene; Phloroglucinol; Real-Time Polymerase Chain Reaction; Terpenes | 2016 |
Photoactivated hypericin increases the expression of SOD-2 and makes MCF-7 cells resistant to photodynamic therapy.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Anthracenes; Breast Neoplasms; Cell Line, Tumor; Estradiol; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Light; Perylene; Photochemotherapy; Photosensitizing Agents; RNA, Messenger; Superoxide Dismutase; Up-Regulation | 2017 |
Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
Topics: Adenocarcinoma; Anthracenes; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Caspase 3; Caspase 9; Colonic Neoplasms; Enzyme Inhibitors; HT29 Cells; Humans; Light; Membrane Potential, Mitochondrial; Mixed Function Oxygenases; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Perylene; Photochemotherapy; Photosensitizing Agents; Proadifen; Reactive Oxygen Species | 2009 |
Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin.
Topics: Adenocarcinoma; Anthracenes; Cell Line; Colon; Colonic Neoplasms; Epithelial Cells; Fetus; Humans; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Reactive Oxygen Species | 2011 |
Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A.
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 7; Cell Proliferation; Enzyme Inhibitors; HT29 Cells; Humans; Lamin Type B; Perylene; Poly(ADP-ribose) Polymerases; Polyenes; Polyunsaturated Alkamides; Radiation-Sensitizing Agents; ras Proteins | 2011 |
The pro-apoptotic and anti-invasive effects of hypericin-mediated photodynamic therapy are enhanced by hyperforin or aristoforin in HT-29 colon adenocarcinoma cells.
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Checkpoints; Cell Proliferation; Colonic Neoplasms; Drug Synergism; Enzyme Activation; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Intracellular Space; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Membrane Potential, Mitochondrial; Neoplasm Invasiveness; Perylene; Phloroglucinol; Photochemotherapy; Reactive Oxygen Species; Terpenes | 2012 |
Hypericin activated by an incoherent light source has photodynamic effects on esophageal cancer cells.
Topics: Adenocarcinoma; Aminolevulinic Acid; Anthracenes; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Esophageal Neoplasms; Female; Humans; Male; Middle Aged; Perylene; Photochemotherapy; Photosensitizing Agents; Time Factors; Tumor Cells, Cultured | 2003 |
Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
Topics: Adenocarcinoma; Animals; Anthracenes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Bridged Bicyclo Compounds; Cell Line, Tumor; Colonic Neoplasms; Digoxin; Humans; Hypericum; LLC-PK1 Cells; Perylene; Phloroglucinol; Plant Extracts; Rifampin; Swine; Terpenes; Transfection | 2005 |
Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin.
Topics: Adenocarcinoma; Anthracenes; Caspase 3; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Radiation; Gene Expression; HeLa Cells; HT29 Cells; Humans; Light; Necrosis; Perylene; Photochemotherapy; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53 | 2007 |
A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin A (2-BA-2-DMHA). 1. Synthesis of 2-BA-2-DMHA and its phototoxicity to MGC803 cells.
Topics: Adenocarcinoma; Adult; Cell Survival; Darkness; DNA Fragmentation; Dose-Response Relationship, Drug; Humans; Light; Molecular Structure; Perylene; Photosensitizing Agents; Quinones; Stomach Neoplasms; Tumor Cells, Cultured | 1998 |
Antisense bcl-2 retrovirus vector increases the sensitivity of a human gastric adenocarcinoma cell line to photodynamic therapy.
Topics: Adenocarcinoma; Base Sequence; DNA Primers; Genetic Vectors; Humans; Perylene; Photochemotherapy; Photosensitizing Agents; Proto-Oncogene Proteins c-bcl-2; Quinones; Retroviridae; RNA, Antisense; Stomach Neoplasms; Tumor Cells, Cultured | 1999 |
Hypericin photosensitization of tumor and metastatic cell lines of human prostate.
Topics: Adenocarcinoma; Anthracenes; Antineoplastic Agents; Humans; Male; Neoplasm Metastasis; Perylene; Photochemotherapy; Prostatic Neoplasms; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2000 |
Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors.
Topics: Adenocarcinoma; Animals; Anthracenes; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Cytokines; Humans; Light; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; Perylene; Photochemotherapy; Radiation-Sensitizing Agents; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Tumor Cells, Cultured | 2000 |
Intracellular localisation of hypericin in human glioblastoma and carcinoma cell lines.
Topics: Adenocarcinoma; Anthracenes; Carcinoma in Situ; Colonic Neoplasms; Female; Glioblastoma; Humans; Perylene; Radiation-Sensitizing Agents; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2001 |
Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure.
Topics: Adenocarcinoma; Anthracenes; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Blotting, Western; Caco-2 Cells; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Multiple; Humans; Hypericum; Image Processing, Computer-Assisted; Microscopy, Fluorescence; Perylene; Protein Kinase C; Rhodamine 123; Ritonavir; Time Factors; Tumor Cells, Cultured; Verapamil | 2001 |